Tech Company Financing Transactions

Cequent Pharmaceuticals Funding Round

Amidzad Partners, New England Partners and Nexus Medical Partners participated in a $1.4 million funding round for Cequent Pharmaceuticals. This venture round was recorded on 9/30/2008.

Transaction Overview

Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$1,350,400
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. Building 700 First Floor
Cambridge, MA 02139
USA
Email Address
Overview
Cequent Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of products to treat gastrointestinal diseases, including familial polyposis, inflammatory bowel disease and colon cancer.
Profile
Cequent Pharmaceuticals LinkedIn Company Profile
Social Media
Cequent Pharmaceuticals Company Twitter Account
Company News
Cequent Pharmaceuticals News
Facebook
Cequent Pharmaceuticals on Facebook
YouTube
Cequent Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Parker
  Peter Parker LinkedIn Profile  Peter Parker Twitter Account  Peter Parker News  Peter Parker on Facebook
Chief Financial Officer
Lisa Velardo
  Lisa Velardo LinkedIn Profile  Lisa Velardo Twitter Account  Lisa Velardo News  Lisa Velardo on Facebook
VP - Bus. Development
Susie Truong
   Susie Truong LinkedIn Profile   Susie Truong Twitter Account   Susie Truong News   Susie Truong on Facebook
VP - R & D
Johannes Fruehauf
  Johannes Fruehauf LinkedIn Profile  Johannes Fruehauf Twitter Account  Johannes Fruehauf News  Johannes Fruehauf on Facebook
VP - Regulatory Affairs
Pamela Fekete
  Pamela Fekete LinkedIn Profile  Pamela Fekete Twitter Account  Pamela Fekete News  Pamela Fekete on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2008: Kabira Technologies venture capital transaction
Next: 9/30/2008: CrossLoop venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary